TRGM Stock Overview
Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Targeted Medical Pharma, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.00% |
| 5 Year Change | -99.29% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| TRGM | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -0.7% |
| 1Y | n/a | 15.8% | 25.9% |
Rentabilidad frente al sector: Datos insuficientes para determinar los resultados de TRGM en comparación con el sector US Pharmaceuticals .
Rentabilidad vs. Mercado: Datos insuficientes para determinar el rendimiento de TRGM frente al mercado US.
Price Volatility
| TRGM volatility | |
|---|---|
| TRGM Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: TRGM no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de TRGM en el último año.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | n/a | https://www.targetedmedicalpharma.com |
Targeted Medical Pharma, Inc. Fundamentals Summary
| TRGM fundamental statistics | |
|---|---|
| Market cap | US$2.95k |
| Earnings (TTM) | -US$3.04m |
| Revenue (TTM) | US$5.26m |
0.0x
P/S Ratio0.0x
P/E RatioIs TRGM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRGM income statement (TTM) | |
|---|---|
| Revenue | US$5.26m |
| Cost of Revenue | US$2.10m |
| Gross Profit | US$3.17m |
| Other Expenses | US$6.21m |
| Earnings | -US$3.04m |
Last Reported Earnings
Dec 31, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did TRGM perform over the long term?
See historical performance and comparison